---
figid: PMC6939386__nihms-1545217-f0004
figlink: pmc/articles/PMC6939386/figure/F4/
number: F4
caption: 'Left penal: D3R exacerbates D1R hypersensitivity and leads to LID. D3R enhances
  the expression of D1R in the surface of neurons, increases the affinity of DA to
  D1R, and activates the downstream signal pathway of D1R, finally induces the oversensitivity
  of D1R, which leads to LID. Right panel: D3R inhibition relieves LID, but shows
  no effect on alleviating PD symptoms. D3R inhibition lead to the lack of D1R in
  the surface of neurons and the decreased affinity of DA on D1R, which induces damaged
  alleviation of DA agonists in PD symptoms. Dopamine (DA); cyclic adenosine monophosphate
  (cAMP); protein kinase A (PKA); γ -aminobutyric acid (GABA); L-DOPA induced dyskinesias
  (LID).'
pmcid: PMC6939386
papertitle: 'Dopamine D3 receptor: a neglected participant in Parkinson Disease pathogenesis
  and treatment?.'
reftext: Pengfei Yang, et al. Ageing Res Rev. ;57:100994-100994.
pmc_ranked_result_index: '83434'
pathway_score: 0.9514551
filename: nihms-1545217-f0004.jpg
figtitle: Relationship between D3R with LID
year: ''
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6939386__nihms-1545217-f0004.html
  '@type': Dataset
  description: 'Left penal: D3R exacerbates D1R hypersensitivity and leads to LID.
    D3R enhances the expression of D1R in the surface of neurons, increases the affinity
    of DA to D1R, and activates the downstream signal pathway of D1R, finally induces
    the oversensitivity of D1R, which leads to LID. Right panel: D3R inhibition relieves
    LID, but shows no effect on alleviating PD symptoms. D3R inhibition lead to the
    lack of D1R in the surface of neurons and the decreased affinity of DA on D1R,
    which induces damaged alleviation of DA agonists in PD symptoms. Dopamine (DA);
    cyclic adenosine monophosphate (cAMP); protein kinase A (PKA); γ -aminobutyric
    acid (GABA); L-DOPA induced dyskinesias (LID).'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PRKACG
  - PRKAR1A
  - PRKAR2A
  - PRKAR2B
  - PRKACA
  - PRKACB
  - PRKAR1B
  - L-DOPA
  - GABA
  - PD
  - LID
genes:
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACG
  entrez: '5568'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1A
  entrez: '5573'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2A
  entrez: '5576'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2B
  entrez: '5577'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACA
  entrez: '5566'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACB
  entrez: '5567'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1B
  entrez: '5575'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACG
  entrez: '5568'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1A
  entrez: '5573'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2A
  entrez: '5576'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2B
  entrez: '5577'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACA
  entrez: '5566'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACB
  entrez: '5567'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1B
  entrez: '5575'
chemicals:
- word: L-DOPA
  source: MESH
  identifier: D007980
- word: GABA
  source: MESH
  identifier: D005680
diseases:
- word: PD
  source: MESH
  identifier: D010300
- word: LID
  source: MESH
  identifier: D004409
figid_alias: PMC6939386__F4
redirect_from: /figures/PMC6939386__F4
figtype: Figure
---
